| Literature DB >> 27197617 |
Pankaj Dhaka1, Deepthi Vijay1, Jess Vergis1, Mamta Negi1, Manesh Kumar1, Vysakh Mohan1, Swapnil Doijad2, Krupali V Poharkar2, Satyaveer Singh Malik1, Sukhadeo Baliram Barbuddhe2, Deepak B Rawool3.
Abstract
INTRODUCTION: Infectious diarrhoea particularly due to pathogenic bacteria is a major health problem in developing countries, including India. Despite significant reports of diarrhoeagenic Escherichia coli (DEC) pathotypes around the globe, studies which address genetic relatedness, antibiogram profile and their correlation with respect to their isolation from different sources are sparse. The present study determines isolation and identification of DEC pathotypes from different sources, their genetic characterisation, antibiogram profile and their correlation if any.Entities:
Keywords: antibiotic resistance; diarrhoeagenic Escherichia coli; genetic diversity; pulsed-field gel electrophoresis; ‘Atypical’ enteroaggregative Escherichia coli
Year: 2016 PMID: 27197617 PMCID: PMC4873563 DOI: 10.3402/iee.v6.31055
Source DB: PubMed Journal: Infect Ecol Epidemiol ISSN: 2000-8686
Details of the DEC pathotypes recovered from different sources along with their target gene amplification.
| Isolate ID | Source | Pathotype(s) | Virulence gene(s) |
|---|---|---|---|
| Human infant isolates | |||
| H005 | Human infant | ETEC | |
| H008 | Human infant | EAEC | |
| H010 | Human infant | EAEC | |
| H058 | Human infant | EPEC | |
| H115 | Human infant | EAEC | |
| H121 | Human infant | EAEC | |
| H123 | Human infant | EAEC | |
| H124 | Human infant | EAEC | |
| H138 | Human infant | EAEC | |
| H140 | Human infant | EAEC | |
| H197 | Human infant | EAEC | |
| H198 | Human infant | EAEC | |
| H313 | Human infant | EAEC | |
| H314 | Human infant | EAEC | |
| H316 | Human infant | EAEC | |
| H319 | Human infant | EAEC | |
| H322 | Human infant | EAEC | |
| H324 | Human infant | EAEC | |
| H325 | Human infant | EAEC | |
| Young animal isolates | |||
| A099 | Canine | EHEC | |
| A103 | Canine | EHEC | |
| A105 | Canine | EHEC | |
| A109 | Canine | EAEC | |
| A187 | Canine | EAEC | |
| A206 | Canine | EAEC | |
| A207 | Canine | EAEC | |
| A209 | Canine | EPEC | |
| A210 | Canine | EAEC | |
| A216 | Canine | EAEC | |
| A219 | Canine | EAEC | |
| A258 | Canine | EAEC | |
| A262 | Canine | EAEC | |
| A265 | Canine | EAEC | |
| A266 | Canine | EAEC | |
| A278 | Canine | EPEC | |
| A279 | Canine | EAEC | |
| A082 | Bovine | EAEC | |
| A084 | Bovine | EAEC | |
| A183 | Bovine | EAEC | |
| A189 | Bovine | EAEC | |
| A185 | Bovine | EAEC | |
| A217 | Bovine | EAEC | |
| A223 | Bovine | EAEC | |
| A101 | Caprine | EHEC | |
| Foods and environmental isolates | |||
| E015 | Poultry meat | EAEC | |
| E017 | Fish | EAEC | |
| E019 | Fish | EAEC | |
| E022 | Mutton | EAEC | |
| E023 | Chevon | EAEC | |
| E065 | Milk | EAEC | |
| E066 | Milk | EAEC | |
| E087 | Milk handler | EAEC | |
| E089 | Milk handler | EAEC | |
| E029 | Vegetable | EAEC | |
| E166 | Vegetable | EAEC | |
| E074 | Animal feed | EPEC | |
| E075 | Animal feed | EAEC | |
| E280 | Sewage | EAEC | |
| E283 | Sewage | EPEC | |
Fig. 1PFGE profile of DEC pathotypes isolated from different sources. The genotypic patterns generated by PFGE were analysed using the Phoretix 1D pro software (Total Lab, UK). The clustering was performed by UPGMA and the dice correlation coefficient.
The antibiogram profile of the DEC pathotypes
| DEC pathotypes percentage (%) for tested antibiotics | ||||||||
|---|---|---|---|---|---|---|---|---|
| Target groups | Antibiotic resistance phenotype | AMP | CIP | COT | CTR | IPM | TE | CTX |
| Human cases ( | R | 94.7% (18/19) | 68.4% (13/19) | 73.7% (14/19) | 78.9% (15/19) | 0 | 84.2% (16/19) | 94.7% (18/19) |
| S | 5.3% (1/19) | 31.6% (6/19) | 26.3% (5/19) | 21.0% (4/19) | 100% (19/19) | 15.8% (3/19) | 5.3% (1/19) | |
| Animal cases ( | R | 96.0% (24/25) | 52.0% (13/25) | 80.0% (20/25) | 64.0% (16/25) | 0 | 88.0% (22/25) | 84.0% (21/25) |
| S | 4.0% (1/25) | 48.0% (12/25) | 20.0% (5/25) | 36.0% (9/25) | 100% (25/25) | 12.0% (3/25) | 16.0% (4/25) | |
| Food and environmental | R | 80.0% (12/15) | 6.7% (1/15) | 66.7% (10/15) | 66.7% (10/15) | 0 | 93.3% (14/15) | 80.0% (12/15) |
| sources ( | S | 20.0% (3/25) | 93.3% (14/15) | 33.3% (5/15) | 33.3% (5/15) | 100% (15/15) | 6.7% (1/15) | 20.0% (3/15) |
| Overall pattern ( | R | 91.5% (54/59) | 45.8% (27/59) | 74.6% (44/59) | 69.5% (41/59) | 0 | 88.1% (52/59) | 86.4% (51/59) |
| S | 8.5% (5/59) | 54.2% (32/59) | 25.4% (15/59) | 30.5% (18/59) | 100% (59/59) | 11.9% (7/59) | 13.6% (8/59) | |
R, resistant; S, sensitive; AMP, ampicillin; CIP, ciprofloxacin; COT, co-trimoxazole; CTR, ceftriaxone; IPM, imipenem; TE, tetracycline; CTX, cefotaxim.
Statistical analysis for resistance pattern among human, animal, and environmental isolates using chi-squared test
| p-Value for different combinations | ||||
|---|---|---|---|---|
| Antibiotics | (a) | (b) | (c) | Inference |
| Ampicillin | 0.842 | 0.185 | 0.102 | All non-significant |
| Ciprofloxacin | 0.272 | 0.000 | 0.004 | Set (a) – non-significant |
| Co-trimoxazole | 0.620 | 0.656 | 0.346 | All non-significant |
| Ceftriaxone | 0.282 | 0.420 | 0.864 | All non-significant |
| Tetracycline | 0.717 | 0.412 | 0.586 | All non-significant |
| Cefotaxim | 0.266 | 0.185 | 0.747 | All non-significant |
(a) Human versus animal isolates; (b) human versus environmental isolates; (c) animal versus environmental isolates.
Correlation of PFGE and antibiogram profile of DEC pathotypes isolates
| Antibiogram of the DEC pathotypes in clusters | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| PFGE clusters | DEC pathotypes | AMP | CIP | COT | CTR | IPM | TE | CTX | Resistant % similarity |
| A | E065 | S | S | R | S | S | R | S | 100% (7/7) |
| E066 | S | S | R | S | S | R | S | ||
| B | A258 | R | S | R | R | S | R | R | 1 and 2: 71.4% (5/7) |
| A265 | R | R | R | R | S | R | S | 1 and 3: 85.7% (6/7) | |
| A266 | R | R | R | R | S | R | R | 2 and 3: 85.7% (6/7) | |
| C | H316 | R | R | R | R | S | R | R | 100% (7/7) |
| H325 | R | R | R | R | S | R | R | ||
| D | A219 | R | R | R | R | S | R | R | 100% (7/7) |
| H121 | R | R | R | R | S | R | R | ||
| E | E166 | R | R | R | S | S | R | R | 85.7% (6/7) |
| A103 | R | R | R | R | S | R | R | ||
| F | A206 | R | R | R | R | S | R | R | 100% (7/7) |
| A207 | R | R | R | R | S | R | R | ||
| G | A082 | R | R | R | S | S | R | R | 100% (7/7) |
| A216 | R | R | R | S | S | R | R | ||
| H | H322 | R | R | R | R | S | R | R | 85.7% (6/7) |
| A185 | R | S | R | R | S | R | R | ||
R, resistant; S, sensitive; AMP, ampicillin; CIP, ciprofloxacin; COT, co-trimoxazole; CTR, ceftriaxone; IPM, imipenem; TE, tetracycline; CTX, cefotaxim.